4processed

Form 4 — Insider Transaction

Avalo Therapeutics, Inc.(AVTX)

Filing Date

June 23, 2026

Accepted

June 23, 2026

Accession No.

0002063957-26-000005

CIK

0001534120

Insider Transactions

InsiderTitleTypeSharesPriceValueOwned AfterSecurityDate
Philip Ron MOther40.2K$040.2KStock Option (Right to Buy)Jun 23, 2026